G. Mateos

Discovery of mitogen-activated protein kinase-interacting kinase 1 inhibitors by a comprehensive fragment-oriented virtual screening approach.

O. Rabal, J. Oyarzábal, Manuel Urbano-Cuadrado, 2010, Journal of medicinal chemistry.

Pim 1 kinase inhibitor ETP-45299 suppresses cellular proliferation and synergizes with PI3K inhibition.

J. Oyarzábal, J. Leal, J. Bischoff, 2011, Cancer letters.

Rapid identification of ETP-46992, orally bioavailable PI3K inhibitor, selective versus mTOR.

M. Barbacid, F. Mulero, P. Pizcueta, 2012, Bioorganic & medicinal chemistry letters.

Chimerism and minimal residual disease monitoring after reduced intensity conditioning (RIC) allogeneic transplantation

R. López-Pérez, M. González, G. Mateos, 2002, Leukemia.

Prognostic value of immunophenotypic detection of minimal residual disease in acute lymphoblastic leukemia.

A Orfao, A. Órfão, J. S. San Miguel, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pim 1 kinase inhibitor ETP-45299 suppresses cellular proliferation and synergizes with PI3K inhibition.

J. Oyarzábal, J. Leal, J. Bischoff, 2011, Cancer letters.